Endocrinology of the aging male

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 25, Issue 2, 2011, Pages 303-319

  Araujo, Andre B ^a   Wittert, Gary A ^a,b  

^a NEW ENGLAND RESEARCH INSTITUTES   (United States)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

aging; androgens; hormones; hypogonadism; men; testosterone

Indexed keywords

ANDROSTANOLONE; ESTROGEN; FOLLITROPIN; LUTEINIZING HORMONE; PLACEBO; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGING; BODY COMPOSITION; BONE METABOLISM; CARDIOVASCULAR DISEASE; CIRCADIAN RHYTHM; COGNITION; CORONARY ARTERY DISEASE; FALLING; FRACTURE; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MEN'S HEALTH; METABOLIC SYNDROME X; MOOD; MORTALITY; MUSCLE STRENGTH; OSTEOPOROSIS; QUALITY OF LIFE; REGULATORY MECHANISM; REVIEW; RISK FACTOR; SEXUAL FUNCTION;

AGING; ANIMALS; DEHYDROEPIANDROSTERONE; DIHYDROTESTOSTERONE; FOLLICLE STIMULATING HORMONE; HUMANS; HYPOGONADISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LUTEINIZING HORMONE; MALE; SEX HORMONE-BINDING GLOBULIN; TESTIS; TESTOSTERONE;

EID: 79952570219     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2010.11.004     Document Type: Review

References (154)

1. Veldhuis JD, Keenan DM & Pincus SM. Regulation of complex pulsatile and rhythmic neuroendocrine systems: the male gonadal axis as a prototype. Progress in Brain Research 2010; 181: 79-110.
2. Iranmanesh A, Mulligan T & Veldhuis JD. Age in men does not determine gonadotropin-releasing hormone's dosedependent stimulation of luteinizing hormone secretion under an exogenous testosterone clamp. Journal of Clinical Endocrinology and Metabolism 2010 Jun; 95(6): 2877-2884.
3. Wu FC, Tajar A, Pye SR et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European male aging study. Journal of Clinical Endocrinology and Metabolism 2008 Jul; 93(7): 2737-2745.
4. Leder BZ, Rohrer JL, Rubin SD et al. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels. Journal of Clinical Endocrinology and Metabolism 2004 Mar; 89(3): 1174-1180. (Pubitemid 38368408)
5. Goodman RL, Lehman MN, Smith JT et al. Kisspeptin neurons in the arcuate nucleus of the ewe express both dynorphin A and neurokinin B. Endocrinology 2007 Dec; 148(12): 5752-5760. (Pubitemid 350146171)
6. Lehman MN, Coolen LM & Goodman RL. Minireview: kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. Endocrinology 2010 Aug; 151(8): 3479-3489.
7. Castellano JM, Bentsen AH, Romero M et al. Acute inflammation reduces kisspeptin immunoreactivity at the arcuate nucleus and decreases responsiveness to kisspeptin independently of its anorectic effects. The American Journal of Physiology - Endocrinology and Metabolism 2010 Jul; 299(1): E54-E61.
8. Brioude F, Bouligand J, Trabado S et al. Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype-phenotype relationships. European Journal of Endocrinology/European Federation of Endocrine Societies 2010 May; 162(5): 835-851.
9. Castellano JM, Roa J, Luque RM et al. KiSS-1/kisspeptins and the metabolic control of reproduction: physiologic roles and putative physiopathological implications. Peptides 2009 Jan; 30(1): 139-145.
10. Young J, Bouligand J, Francou B et al. TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans. Journal of Clinical Endocrinology and Metabolism 2010 May; 95(5): 2287-2295.
11. Wakabayashi Y, Nakada T, Murata K et al. Neurokinin B and dynorphin A in kisspeptin neurons of the arcuate nucleus participate in generation of periodic oscillation of neural activity driving pulsatile gonadotropin-releasing hormone secretion in the goat. Journal of Neuroscience 2010 Feb 24; 30(8): 3124-3132.
12. Wildt L, Hausler A, Marshall G et al. Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey. Endocrinology 1981 Aug; 109(2): 376-385. (Pubitemid 11040187)
13. Woerdeman J, Kaufman JM & de Ronde W. In young men, a moderate inhibition of testosterone synthesis capacity is only partly compensated by increased activity of the pituitary and the hypothalamus. Clinical Endocrinology 2010 Jan; 72(1): 76-80.
14. Kumar TR. FSHbeta knockout mouse model: a decade ago and into the future. Endocrine 2009 Aug; 36(1): 1-5.
15. Peltoketo H, Rivero-Muller A, Ahtiainen P et al. Consequences of genetic manipulations of gonadotrophins and gonadotrophin receptors in mice. Annales d Endocrinologie 2010 May; 71(3): 170-176.
16. Kumanov P, Nandipati KC, Tomova A et al. Significance of inhibin in reproductive pathophysiology and current clinical applications. Reproductive Biomedicine Online 2005 Jun; 10(6): 786-812.
17. de Kretser DM, Buzzard JJ, Okuma Y et al. The role of activin, follistatin and inhibin in testicular physiology. Molecular and Cellular Endocrinology 2004 Oct 15; 225(1-2): 57-64. (Pubitemid 39297055)
18. Meachem SJ, Nieschlag E & Simoni M. Inhibin B in male reproduction: pathophysiology and clinical relevance. European Journal of Endocrinology/ European Federation of Endocrine Societies 2001 Nov; 145(5): 561-571. (Pubitemid 33061900)
19. Van Thiel DH, Sherins RJ, Myers Jr. GH et al. Evidence for a specific seminiferous tubular factor affecting folliclestimulating hormone secretion in man. Journal of Clinical Investigation 1972 Apr; 51(4): 1009-1019.
20. Jorgensen N, Liu F, Andersson AM et al. Serum inhibin-b in fertile men is strongly correlated with low but not high sperm counts: a coordinated study of 1,797 European and US men. Fertility and Sterility 2010 Nov; 94(6): 2128-2134.
21. Scott HM, Mason JI & Sharpe RM. Steroidogenesis in the fetal testis and its susceptibility to disruption by exogenous compounds. Endocrine Reviews 2009 Dec; 30(7): 883-925.
22. Purnell JQ, Brandon DD, Isabelle LM et al. Association of 24-hour cortisol production rates, cortisol-binding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. Journal of Clinical Endocrinology and Metabolism 2004 Jan; 89(1): 281-287. (Pubitemid 38183894)
23. Koeva Y, Bakalska M, Atanassova N et al. Age-related changes in the expression of 11beta-hydroxysteroid dehydrogenase type 2 in rat leydig cells. Folia Histochemica et Cytobiologica 2009; 47(2): 281-287.
24. Selva DM, Hogeveen KN, Innis SM et al. Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. Journal of Clinical Investigation 2007 Dec; 117(12): 3979-3987. (Pubitemid 350224107)
25. Selva DM & Hammond GL. Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4alpha. Journal of Molecular Endocrinology 2009 Jul; 43(1): 19-27.
26. Atlantis E, Martin SA, Haren MT et al. Demographic, physical and lifestyle factors associated with androgen status: the florey adelaide male ageing study (FAMAS). Clinical Endocrinology 2009 Aug; 71(2): 261-272.
27. Coviello AD, Lakshman K, Mazer NA et al. Differences in the apparent metabolic clearance rate of testosterone in young and older men with gonadotropin suppression receiving graded doses of testosterone. Journal of Clinical Endocrinology and Metabolism 2006 Nov; 91(11): 4669-4675. (Pubitemid 44833455)
28. Grino PB, Griffin JE & Wilson JD. Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. Endocrinology 1990 Feb; 126(2): 1165-1172. (Pubitemid 20079537)
29. Penning TM, Jin Y, Rizner TL et al. Pre-receptor regulation of the androgen receptor. Molecular and Cellular Endocrinology 2008 Jan 16; 281(1-2): 1-8. (Pubitemid 350296604)
30. Sharpe RM. The roles of oestrogen in the male. Trends in Endocrinology and Metabolism 1998 Nov; 9(9): 371-377. (Pubitemid 28489836)
31. Jones ME, Boon WC, Proietto J et al. Of mice and men: the evolving phenotype of aromatase deficiency. Trends in Endocrinology and Metabolism 2006 Mar; 17(2): 55-64.
32. Brann DW, Dhandapani K, Wakade C et al. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 2007 May; 72(5): 381-405. (Pubitemid 46602478)
33. Micevych P & Dominguez R. Membrane estradiol signaling in the brain. Frontiers in Neuroendocrinology 2009 Aug; 30 (3): 315-327.
34. Toran-Allerand CD. Estrogen and the brain: beyond ER-alpha, ER-beta, and 17beta-estradiol. Annals of the New York Academy of Sciences 2005 Jun; 1052: 136-144.
35. Lakshman KM, Kaplan B, Travison TG et al. The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. Journal of Clinical Endocrinology and Metabolism 2010 Aug; 95(8): 3955-3964.
36. Roselli CE, Liu M & Hurn PD. Brain aromatization: classic roles and new perspectives. Seminars in Reproductive Medicine 2009 May; 27(3): 207-217.
37. Simpson ER, Clyne C, Rubin G et al. Aromatase-a brief overview. Annual Review of Physiology 2002; 64: 93-127.
38. Naftolin F, Garcia-Segura LM, Horvath TL et al. Estrogen-induced hypothalamic synaptic plasticity and pituitary sensitization in the control of the estrogen-induced gonadotrophin surge. Reproductive Sciences 2007 Feb; 14(2): 101-116. (Pubitemid 351168830)
39. Rosner W, Auchus RJ, Azziz R et al. Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. Journal of Clinical Endocrinology and Metabolism 2007 Feb; 92(2): 405-413.
40. Rosner W & Vesper H. Toward excellence in testosterone testing: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2010 Oct; 95(10): 4542-4548.
41. Veldhuis JD, King JC, Urban RJ et al. Operating characteristics of the male hypothalamo-pituitary-gonadal axis: pulsatile release of testosterone and follicle-stimulating hormone and their temporal coupling with luteinizing hormone. Journal of Clinical Endocrinology and Metabolism 1987 Nov; 65(5): 929-941. (Pubitemid 17162642)
42. Vermeulen A & Verdonck G. Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men. Journal of Clinical Endocrinology and Metabolism 1992 Apr; 74(4): 939-942.
43. Brambilla DJ, O'Donnell AB, Matsumoto AM et al. Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men. Clinical Endocrinology 2007 Dec; 67(6): 853-862. (Pubitemid 350135128)
44. Diver MJ, Imtiaz KE, Ahmad AM et al. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clinical Endocrinology 2003 Jun; 58(6): 710-717. (Pubitemid 36702730)
45. Bremner WJ, Vitiello MV & Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. Journal of Clinical Endocrinology and Metabolism 1983 Jun; 56(6): 1278-1281. (Pubitemid 13055125)
46. Brambilla DJ, Matsumoto AM, Araujo AB et al. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. Journal of Clinical Endocrinology and Metabolism 2009 Mar; 94(3): 907-913.
47. Wu FC. Commentary: guideline for male testosterone therapy: a European perspective. Journal of Clinical Endocrinology and Metabolism 2007 Feb; 92(2): 418-419.
48. Heinemann LAJ, Zimmermann T, Vermeulen A et al. A new 'Aging Male's Symptoms' (AMS) rating scale. The Aging Male 1999; 2: 105-114.
49. Morley JE, Charlton E, Patrick P et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000; 49(9): 1239-1242.
50. Smith KW, Feldman HA & McKinlay JB. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clinical Endocrinology 2000 Dec; 53(6): 703-711. (Pubitemid 32096681)
51. Wu FC, Tajar A, Beynon JM et al. Identification of late-onset hypogonadism in middle-aged and elderly men. New England Journal of Medicine 2010 Jun 16.
52. Araujo AB, Esche GR, Kupelian V et al. Prevalence of symptomatic androgen deficiency in men. Journal of Clinical Endocrinology and Metabolism 2007 Nov; 92(11): 4241-4247.
53. Zitzmann M, Faber S & Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. Journal of Clinical Endocrinology and Metabolism 2006 Nov; 91(11): 4335-4343. (Pubitemid 44833407)
54. Kelleher S, Conway AJ & Handelsman DJ. Blood testosterone threshold for androgen deficiency symptoms. Journal of Clinical Endocrinology and Metabolism 2004 Aug; 89(8): 3813-3817. (Pubitemid 39071477)
55. Feldman HA, Longcope C, Derby CA et al. Age trends in the level of serum testosterone and other hormones in middleaged men: longitudinal results from the Massachusetts male aging study. Journal of Clinical Endocrinology and Metabolism 2002 Feb; 87(2): 589-598.
56. Zmuda JM, Cauley JA, Kriska A et al. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former multiple risk factor intervention trial participants. American Journal of Epidemiology 1997 Oct 15; 146(8): 609-617. (Pubitemid 27454548)
57. Morley JE, Kaiser FE, Perry 3rd HM et al. Longitudinal changes in testosterone, luteinizing hormone, and folliclestimulating hormone in healthy older men. Metabolism 1997 Apr; 46(4): 410-413. (Pubitemid 27172090)
58. Travison TG, Araujo AB, Kupelian V et al. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. Journal of Clinical Endocrinology and Metabolism 2007 Feb; 92(2): 549-555.
59. Orentreich N, Brind JL, Vogelman JH et al. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. Journal of Clinical Endocrinology and Metabolism 1992 Oct; 75(4): 1002-1004.
60. Belanger A, Candas B, Dupont A et al. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. Journal of Clinical Endocrinology and Metabolism 1994 Oct; 79(4): 1086-1090. (Pubitemid 24342252)
61. Gray A, Feldman HA, McKinlay JB et al. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study. Journal of Clinical Endocrinology and Metabolism 1991; 73(5): 1016-1025. (Pubitemid 21901140)
62. Barrett-Connor E, Von Muhlen DG & Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. Journal of Clinical Endocrinology and Metabolism 1999 Feb; 84(2): 573-577. (Pubitemid 29075686)
63. Deslypere JP & Vermeulen A. Leydig cell function in normal men: effect of age, life-style, residence, diet, and activity. Journal of Clinical Endocrinology and Metabolism 1984 Nov; 59(5): 955-962. (Pubitemid 14020699)
64. Zumoff B, Strain GW, Kream J et al. Age variation of the 24-hour mean plasma concentrations of androgens, estrogens, and gonadotropins in normal adult men. Journal of Clinical Endocrinology and Metabolism 1982 Mar; 54(3): 534-538. (Pubitemid 13233801)
65. Mohr BA, Feldman HA, Kalish LA et al. Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts male aging study. Urology 2001 May; 57(5): 930-935. (Pubitemid 32405316)
66. Orwoll E, Lambert LC, Marshall LM et al. Testosterone and estradiol among older men. Journal of Clinical Endocrinology and Metabolism 2006 Apr; 91(4): 1336-1344.
67. Araujo AB, Travison TG, Leder BZ et al. Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men. Journal of Clinical Endocrinology and Metabolism 2008 Jun; 93(6): 2135-2141. (Pubitemid 351831527)
68. Bagatell CJ & Bremner WJ. Androgens in men-uses and abuses. New England Journal of Medicine 1996 Mar 14; 334(11): 707-714.
69. Anand-Ivell R,Wohlgemuth J, Haren MT et al. Peripheral INSL3 concentrations decline with age in a large population of Australian men. International Journal of Andrology 2006 Dec; 29(6): 618-626. (Pubitemid 44800241)
70. Harman SM, Metter EJ, Tobin JD et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging. Journal of Clinical Endocrinology and Metabolism 2001; 86(2): 724-731. (Pubitemid 32207487)
71. Araujo AB, O'Donnell AB, Brambilla DJ et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts male aging study. Journal of Clinical Endocrinology and Metabolism 2004 Dec; 89 (12): 5920-5926. (Pubitemid 39628393)
72. Travison TG, Araujo AB, O'Donnell AB et al. A population-level decline in serum testosterone levels in American men. Journal of Clinical Endocrinology and Metabolism 2007 Jan; 92(1): 196-202.
73. Carlsen E, Giwercman A, Keiding N et al. Evidence for decreasing quality of semen during past 50 years. British Medical Journal 1992 Sep 12; 305(6854): 609-613.
74. Andersson AM, Jensen TK, Juul A et al. Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. Journal of Clinical Endocrinology and Metabolism 2007 Dec; 92(12): 4696-4705. (Pubitemid 350223446)
75. Simon D, Preziosi P, Barrett-Connor E et al. Interrelation between plasma testosterone and plasma insulin in healthy adult men: the telecom study. Diabetologia 1992 Feb; 35(2): 173-177.
76. Ferrini RL & Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. American Journal of Epidemiology 1998 Apr 15; 147(8): 750-754. (Pubitemid 28183274)
77. Gray A, Jackson DN & McKinlay JB. The relation between dominance, anger, and hormones in normally aging men: results from the Massachusetts male aging study. Psychosomatic Medicine 1991; 53(4): 375-385.
78. Derby CA, Zilber S, Brambilla D et al. Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts male ageing study. Clinical Endocrinology 2006 Jul; 65(1): 125-131.
79. Longcope C, Feldman HA, McKinlay JB et al. Diet and sex hormone-binding globulin. Journal of Clinical Endocrinology and Metabolism 2000; 85(1): 293-296. (Pubitemid 32268828)
80. Liverman CT & Blazer DG (eds.). Testosterone and aging: clinical research directions. Washington D.C.: The National Academies Press, 2004.
81. Travison TG, Morley JE, Araujo AB et al. The relationship between libido and testosterone levels in aging men. Journal of Clinical Endocrinology and Metabolism 2006 Jul; 91(7): 2509-2513. (Pubitemid 44024610)
82. Shabsigh R. Testosterone therapy in erectile dysfunction and hypogonadism. The Journal of Sexual Medicine 2005 Nov; 2 (6): 785-792. (Pubitemid 41727391)
83. Schiavi RC, White D, Mandeli J et al. Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction. Archives of Sexual Behavior 1997 Jun; 26(3): 231-241. (Pubitemid 27188130)
84. Isidori AM, Giannetta E, Gianfrilli D et al. Effects of testosterone on sexual function in men: results of a meta-analysis. Clinical Endocrinology 2005 Oct; 63(4): 381-394. (Pubitemid 41442332)
85. Gray PB, Singh AB, Woodhouse LJ et al. Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. Journal of Clinical Endocrinology and Metabolism 2005 Jul; 90(7): 3838-3846. (Pubitemid 41058141)
86. Kupelian V, Shabsigh R, Travison TG et al. Is there a relationship between sex hormones and erectile dysfunction? Results from the Massachusetts male aging study. Journal of Urology 2006 Dec; 176(6 Pt 1): 2584-2588. (Pubitemid 44665980)
87. Gooren LJ. Androgen levels and sex functions in testosterone-treated hypogonadal men. Archives of Sexual Behavior 1987 Dec; 16(6): 463-473.
88. Araujo AB, Travison TG, Bhasin S et al. Association between testosterone and estradiol and age-related decline in physical function in a diverse sample of men. Journal of the American Geriatrics Society 2008 Nov; 56(11): 2000-2008.
89. Isidori AM, Giannetta E, Greco EA et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clinical Endocrinology 2005 Sep; 63(3): 280-293. (Pubitemid 41233445)
90. Singh R, Artaza JN, Taylor WE et al. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 2006 Jan; 147(1): 141-154. (Pubitemid 43004269)
91. Brodsky IG, Balagopal P & Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men-a clinical research center study. Journal of Clinical Endocrinology and Metabolism 1996 Oct; 81(10): 3469-3475. (Pubitemid 26339901)
92. Maggio M, Basaria S, Ble A et al. Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. Journal of Clinical Endocrinology and Metabolism 2006 Jan; 91(1): 345-347. (Pubitemid 43069161)
93. Kupelian V, Chiu GR, Araujo AB et al. Association of sex hormones and C-reactive protein levels in men. Clinical Endocrinology 2010 Apr; 72(4): 527-533.
94. Schaap LA, Pluijm SM, Deeg DJ et al. Low testosterone levels and decline in physical performance and muscle strength in older men: findings from two prospective cohort studies. Clinical Endocrinology 2008 Jan; 68(1): 42-50. (Pubitemid 350243480)
95. Krasnoff JB, Basaria S, Pencina MJ et al. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the framingham offspring study. Journal of Clinical Endocrinology and Metabolism 2010 Apr 9.
96. Orwoll E, Lambert LC, Marshall LM et al. Endogenous testosterone levels, physical performance, and fall risk in older men. Archives of Internal Medicine 2006 Oct 23; 166(19): 2124-2131. (Pubitemid 44631401)
97. Szulc P, Claustrat B, Marchand F et al. Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study. Journal of Clinical Endocrinology and Metabolism 2003 Nov; 88(11): 5240-5247. (Pubitemid 37452722)
98. Schaap LA, Pluijm SM, Smit JH et al. The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women. Clinical Endocrinology 2005 Aug; 63(2): 152-160. (Pubitemid 41097983)
99. Bhasin S, Calof OM, Storer TWet al. Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nature Clinical Practice Endocrinology & Metabolism 2006 Mar; 2(3): 146-159.
100. Storer TW, Magliano L, Woodhouse L et al. Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. Journal of Clinical Endocrinology and Metabolism 2003 Apr; 88(4): 1478-1485. (Pubitemid 36636978)
101. Storer TW, Woodhouse L, Magliano L et al. Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men. Journal of the American Geriatrics Society 2008 Nov; 56 (11): 1991-1999.
102. Sattler FR, Castaneda-Sceppa C, Binder EF et al. Testosterone and growth hormone improve body composition and muscle performance in older men. Journal of Clinical Endocrinology and Metabolism 2009 Jun; 94(6): 1991-2001.
103. Srinivas-Shankar U, Roberts SA, Connolly MJ et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: A randomized, double-blind, placebocontrolled study. Journal of Clinical Endocrinology and Metabolism 2010 Jan 8.
104. Basaria S, Coviello AD, Travison TG et al. Adverse events associated with testosterone administration. New England Journal of Medicine 2010 Jun 30.
105. Khosla S, Melton 3rd LJ, Atkinson EJ et al. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. Journal of Clinical Endocrinology and Metabolism 1998 Jul; 83(7): 2266-2274. (Pubitemid 28503012)
106. Fink HA, Ewing SK, Ensrud KE et al. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. Journal of Clinical Endocrinology and Metabolism 2006 Oct; 91(10): 3908-3915. (Pubitemid 44536863)
107. Falahati-Nini A, Riggs BL, Atkinson EJ et al. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. Journal of Clinical Investigation 2000 Dec; 106(12): 1553-1560. (Pubitemid 32038592)
108. Leblanc ES, Nielson CM, Marshall LM et al. The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. Journal of Clinical Endocrinology and Metabolism 2009 Jul 7.
109. Mellstrom D, Vandenput L, Mallmin H et al. Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. Journal of Bone and Mineral Research 2008 Oct; 23(10): 1552-1560.
110. Stone KL, Seeley DG, Lui LY et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures. Journal of Bone and Mineral Research 2003 Nov; 18(11): 1947-1954. (Pubitemid 37377443)
111. Benito M, Gomberg B, Wehrli FW et al. Deterioration of trabecular architecture in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 2003 Apr; 88(4): 1497-1502. (Pubitemid 36623360)
112. Khosla S, Melton 3rd LJ, Achenbach SJ et al. Hormonal and biochemical determinants of trabecular microstructure at the ultradistal radius in women and men. Journal of Clinical Endocrinology and Metabolism 2006 Mar; 91(3): 885-891. (Pubitemid 43357754)
113. Benito M, Vasilic B, Wehrli FW et al. Effect of testosterone replacement on trabecular architecture in hypogonadal men. Journal of Bone and Mineral Research 2005 Oct; 20(10): 1785-1791. (Pubitemid 41361879)
114. Tracz MJ, Sideras K, Bolona ER et al. Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. Journal of Clinical Endocrinology and Metabolism 2006 Jun; 91(6): 2011-2016. (Pubitemid 43854973)
115. Basaria S, Muller DC, Carducci MA et al. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 2006 Feb 1; 106(3): 581-588. (Pubitemid 43157621)
116. Laaksonen DE, Niskanen L, Punnonen K et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004 May; 27(5): 1036-1041. (Pubitemid 38579762)
117. Kupelian V, Page ST, Araujo AB et al. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. Journal of Clinical Endocrinology and Metabolism 2006 Mar; 91(3): 843-850. (Pubitemid 43357748)
118. Ding EL, Song Y, Malik VS et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. Journal of the American Medical Association 2006 Mar 15; 295(11): 1288-1299.
119. Barrett-Connor E, Khaw KT & Yen SS. Endogenous sex hormone levels in older adult men with diabetes mellitus. American Journal of Epidemiology 1990 Nov; 132(5): 895-901. (Pubitemid 20363668)
120. Lakshman KM, Bhasin S & Araujo AB. Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2010 May; 65 (5): 503-509.
121. Simon D, Charles MA, Lahlou N et al. Androgen therapy improves insulin sensitivity and decreases leptin level in healthy adult men with low plasma total testosterone: a 3-month randomized placebo-controlled trial. Diabetes Care 2001 Dec; 24(12): 2149-2151.
122. Kapoor D, Aldred H, Clark S et al. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care 2007 Apr; 30(4): 911-917. (Pubitemid 46556586)
123. Marin P. Testosterone and regional fat distribution. Obesity Research 1995 Nov; 3(Suppl. 4): 609S-612S.
124. Sader MA, Griffiths KA, Skilton MR et al. Physiological testosterone replacement and arterial endothelial function in men. Clinical Endocrinology 2003 Jul; 59(1): 62-67. (Pubitemid 36774109)
125. Ong PJ, Patrizi G, ChongWC et al. Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. American Journal of Cardiology 2000 Jan 15; 85(2): 269-272. (Pubitemid 30026117)
126. Wu FC & von Eckardstein A. Androgens and coronary artery disease. Endocrine Reviews 2003 Apr; 24(2): 183-217. (Pubitemid 36515284)
127. Arnlov J, Pencina MJ, Amin S et al. Endogenous sex hormones and cardiovascular disease incidence in men. Annals of Internal Medicine 2006 Aug 1; 145(3): 176-184. (Pubitemid 46780562)
128. English KM, Steeds RP, Jones TH et al. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 2000 Oct 17; 102(16): 1906-1911.
129. Haddad RM, Kennedy CC, Caples SM et al. Testosterone and cardiovascular risk in men: a systematic review and metaanalysis of randomized placebo-controlled trials. Mayo Clinic Proceedings 2007 Jan; 82(1): 29-39. (Pubitemid 46036319)
130. Janowsky JS. The role of androgens in cognition and brain aging in men. Neuroscience 2006; 138(3): 1015-1020.
131. Seidman SN, Araujo AB, Roose SP et al. Low testosterone levels in elderly men with dysthymic disorder. American Journal of Psychiatry 2002 Mar; 159(3): 456-459. (Pubitemid 34184742)
132. Wang C, Alexander G, Berman N et al. Testosterone replacement therapy improves mood in hypogonadal men-a clinical research center study. Journal of Clinical Endocrinology and Metabolism 1996 Oct; 81(10): 3578-3583. (Pubitemid 26339918)
133. Snyder PJ, Peachey H, Berlin JA et al. Effects of testosterone replacement in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 2000 Aug; 85(8): 2670-2677. (Pubitemid 32269134)
134. Carrero JJ, Qureshi AR, Parini P et al. Low serum testosterone increases mortality risk among male dialysis patients. Journal of the American Society of Nephrology 2009 Mar; 20(3): 613-620.
135. Laughlin GA, Barrett-Connor E & Bergstrom J. Low serum testosterone and mortality in older men. Journal of Clinical Endocrinology and Metabolism 2008 Jan; 93(1): 68-75.
136. Shores MM, Moceri VM, Gruenewald DA et al. Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit. Journal of the American Geriatrics Society 2004 Dec; 52(12): 2077-2081. (Pubitemid 41725027)
137. Shores MM, Matsumoto AM, Sloan KL et al. Low serum testosterone and mortality in male veterans. Archives of Internal Medicine 2006 Aug 14-28; 166(15): 1660-1665. (Pubitemid 44232378)
138. Vikan T, Schirmer H, Njolstad I et al. Low testosterone levels and SHBG levels and high estradiol levels are independent predictors of type 2 diabetes in men. European Journal of Endocrinology/European Federation of Endocrine Societies 2010 Jan 8.
139. Menke A, Guallar E, Rohrmann S et al. Sex steroid hormone concentrations and risk of death in us men. American Journal of Epidemiology 2010 Mar 1; 171(5): 583-592.
140. Haring R, Volzke H, Steveling A et al. Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. European Heart Journal 2010 Feb 17.
141. Ponikowska B, Jankowska EA, Maj J et al. Gonadal and adrenal androgen deficiencies as independent predictors of increased cardiovascular mortality in men with type II diabetes mellitus and stable coronary artery disease. International Journal of Cardiology 2009 Apr 21.
142. Khaw KT, Dowsett M, Folkerd E et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study. Circulation 2007 Dec 4; 116(23): 2694-2701. (Pubitemid 350291241)
143. Lehtonen A, Huupponen R, Tuomilehto J et al. Serum testosterone but not leptin predicts mortality in elderly men. Age and Ageing 2008.
144. Tivesten A, Vandenput L, Labrie F et al. Low serum testosterone and estradiol predict mortality in elderly men. Journal of Clinical Endocrinology and Metabolism 2009 Jul; 94(7): 2482-2488.
145. Guder G, Frantz S, Bauersachs J et al. Low circulating androgens and mortality risk in heart failure. Heart 2009 Oct 28.
146. Jankowska EA, Rozentryt P, Ponikowska B et al. Circulating estradiol and mortality in men with systolic chronic heart failure. Journal of the American Medical Association 2009 May 13; 301(18): 1892-1901.
147. Malkin CJ, Pugh PJ, Morris PD et al. Low serum testosterone and increased mortality in men with coronary heart disease. Heart 2010 Nov; 96(22): 1821-1825.
148. Araujo AB, Kupelian V, Page ST et al. Sex steroids and all-cause and cause-specific mortality in men. Archives of Internal Medicine 2007 Jun 25; 167(12): 1252-1260. (Pubitemid 46998496)
149. Barrett-Connor E & Khaw KT. Endogenous sex hormones and cardiovascular disease in men. A prospective populationbased study. Circulation 1988 Sep; 78(3): 539-545.
150. Haffner SM, Shaten J, Stern MP et al. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT research group. Multiple risk factor intervention trial. American Journal of Epidemiology 1996 May 1; 143(9): 889-897. (Pubitemid 26131096)
151. Maggio M, Lauretani F, Ceda GP et al. Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the chianti area (InCHIANTI) study. Archives of Internal Medicine 2007 Nov 12; 167(20): 2249-2254. (Pubitemid 350106746)
152. Smith GD, Ben-Shlomo Y, Beswick A et al. Cortisol, testosterone, and coronary heart disease: prospective evidence from the caerphilly study. Circulation 2005 Jul 19; 112(3): 332-340. (Pubitemid 41022073)
153. Szulc P, Claustrat B & Delmas PD. Serum concentrations of 17beta-E2 and 25-hydroxycholecalciferol (25OHD) in relation to all-cause mortality in older men-the MINOS study. Clinical Endocrinology 2009 Oct; 71(4): 594-602.
154. Platz EA. Low testosterone and risk of premature death in older men: analytical and preanalytical issues in measuring circulating testosterone. Clinical Chemistry 2008 Jul; 54(7): 1110-1112. (Pubitemid 352009685)